{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T20:40:24Z","timestamp":1775076024186,"version":"3.50.1"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of China","doi-asserted-by":"publisher","award":["2017ZX09101001"],"award-info":[{"award-number":["2017ZX09101001"]}],"id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of China","doi-asserted-by":"publisher","award":["005-003"],"award-info":[{"award-number":["005-003"]}],"id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81972892"],"award-info":[{"award-number":["81972892"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81673364"],"award-info":[{"award-number":["81673364"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BK20150702"],"award-info":[{"award-number":["BK20150702"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007289","name":"Nanjing Medical University","doi-asserted-by":"publisher","award":["2016NJMU105"],"award-info":[{"award-number":["2016NJMU105"]}],"id":[{"id":"10.13039\/501100007289","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Postgraduate Research & Practice Innovation Program of Jiangsu Province","award":["KYCX17_0674"],"award-info":[{"award-number":["KYCX17_0674"]}]},{"name":"Postgraduate Research & Practice Innovation Program of Jiangsu Province","award":["KYCX19_0644"],"award-info":[{"award-number":["KYCX19_0644"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.biomaterials.2019.119575","type":"journal-article","created":{"date-parts":[[2019,10,21]],"date-time":"2019-10-21T02:30:31Z","timestamp":1571625031000},"page":"119575","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Fumaryl diketopiperazine based effervescent microparticles to escape macrophage phagocytosis for enhanced treatment of pneumonia via pulmonary delivery"],"prefix":"10.1016","volume":"228","author":[{"given":"Qiyue","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gujie","family":"Mi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongsheng","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yerong","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas J.","family":"Webster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiasheng","family":"Tu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.biomaterials.2019.119575_bib1","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1089\/jamp.2010.0855","article-title":"Development of an inhaled dry-powder formulation of tobramycin using PulmoSphere\u2122 technology","volume":"24","author":"Geller","year":"2011","journal-title":"J. Aerosol Med. Pulm. Drug Deliv."},{"issue":"6","key":"10.1016\/j.biomaterials.2019.119575_bib2","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s40261-013-0082-0","article-title":"Inhalation of a dry powder ciprofloxacin formulation in healthy subjects: a phase I study","volume":"33","author":"Heino","year":"2013","journal-title":"Clin. Drug Investig."},{"key":"10.1016\/j.biomaterials.2019.119575_bib3","article-title":"In vitro aerosol delivery performance of tobramycin inhalation powder for inhalation (TOBI\u00ae Podhaler\u2122) using inspiratory flow profiles from cystic fibrosis patients","volume":"48","author":"Haynes","year":"2013","journal-title":"Pediatr. Pulmonol."},{"key":"10.1016\/j.biomaterials.2019.119575_bib4","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.addr.2014.08.013","article-title":"Inhaled antimicrobial therapy-Barriers to effective treatment","volume":"85","author":"Weers","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"3","key":"10.1016\/j.biomaterials.2019.119575_bib5","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1039\/C8BM01197D","article-title":"Up-to-date vaccine delivery systems: robust immunity elicited by multifarious nanomaterials upon administration through diverse routes","volume":"7","author":"Hou","year":"2019","journal-title":"Biomaterials Science"},{"issue":"12","key":"10.1016\/j.biomaterials.2019.119575_bib6","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.tibtech.2007.09.005","article-title":"Nanoparticles for drug delivery to the lungs","volume":"25","author":"Sung","year":"2007","journal-title":"Trends Biotechnol."},{"issue":"1\u20132","key":"10.1016\/j.biomaterials.2019.119575_bib7","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jconrel.2007.03.022","article-title":"Particle shape: a new design parameter for micro- and nanoscale drug delivery carriers","volume":"121","author":"Champion","year":"2007","journal-title":"J. Control. Release"},{"key":"10.1016\/j.biomaterials.2019.119575_bib8","series-title":"Chapter 5: Delivery of Drugs by the Pulmonary Route; Modern Pharmaceutics","author":"Hickey","year":"2009"},{"key":"10.1016\/j.biomaterials.2019.119575_bib9","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jconrel.2014.05.058","article-title":"Controlled delivery of inhaled therapeutic agents","volume":"190","author":"Hickey","year":"2014","journal-title":"J. Control. Release"},{"issue":"6","key":"10.1016\/j.biomaterials.2019.119575_bib10","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/joim.12280","article-title":"Emerging concepts in dendrimer-based nanomedicine: from design principles to clinical applications","volume":"276","author":"Kannan","year":"2014","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.biomaterials.2019.119575_bib11","first-page":"59","article-title":"Design and physicochemical characterization of advanced spray-dried tacrolimus multifunctional particles for inhalation","volume":"7","author":"Wu","year":"2013","journal-title":"Drug Des. Dev. Ther."},{"issue":"6","key":"10.1016\/j.biomaterials.2019.119575_bib12","first-page":"652","article-title":"Drug properties affecting aerosol behavior","volume":"45","author":"Suarez","year":"2000","journal-title":"Respir. Care"},{"issue":"5","key":"10.1016\/j.biomaterials.2019.119575_bib13","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.nano.2015.01.007","article-title":"Inhalable nanoparticulate powders for respiratory delivery. Invited review","volume":"11","author":"Muralidharan","year":"2015","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"issue":"1\u20132","key":"10.1016\/j.biomaterials.2019.119575_bib14","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ijpharm.2015.12.072","article-title":"Dry powder inhaler formulation of high-payload antibiotic nanoparticle complex intended for bronchiectasis therapy: spray drying versus spray freeze drying preparation","volume":"499","author":"Yu","year":"2016","journal-title":"Int. J. Pharm."},{"issue":"11","key":"10.1016\/j.biomaterials.2019.119575_bib15","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1002\/jps.2600791113","article-title":"Effect of hydrophobic coating on the behavior of a hygroscopic aerosol powder in an environment of controlled temperature and relative humidity","volume":"79","author":"Hickey","year":"1990","journal-title":"J. Pharm. Sci."},{"issue":"2","key":"10.1016\/j.biomaterials.2019.119575_bib16","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1021\/js980321x","article-title":"Stability and surface activity of lactate dehydrogenase in spray-dried trehalose","volume":"88","author":"Adler","year":"1999","journal-title":"J. Pharm. Sci."},{"issue":"2","key":"10.1016\/j.biomaterials.2019.119575_bib17","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ijpharm.2010.01.028","article-title":"Characterisation and functionality of inhalation anhydrous lactose","volume":"390","author":"Pitchayajittipong","year":"2010","journal-title":"Int. J. Pharm."},{"issue":"1\u20132","key":"10.1016\/j.biomaterials.2019.119575_bib18","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.ijpharm.2007.08.013","article-title":"Effect of particle size of dry powder mannitol on the lung deposition in healthy volunteers","volume":"349","author":"Glover","year":"2008","journal-title":"Int. J. Pharm."},{"issue":"1\u20132","key":"10.1016\/j.biomaterials.2019.119575_bib19","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0378-5173(00)00553-6","article-title":"The use of different sugars as fine and coarse carriers for aerosolized salbutamol sulphate","volume":"208","author":"Tee","year":"2000","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.biomaterials.2019.119575_bib20","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ejpb.2005.11.003","article-title":"Preparation and in vitro evaluation of lipidic carriers and fillers for inhalation","volume":"63","author":"Sebti","year":"2006","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"2","key":"10.1016\/j.biomaterials.2019.119575_bib21","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jconrel.2009.03.019","article-title":"Aerosolized liposomes with dipalmitoyl phosphatidylcholine enhance pulmonary insulin delivery","volume":"137","author":"Chono","year":"2009","journal-title":"J. Control. Release"},{"issue":"2","key":"10.1016\/j.biomaterials.2019.119575_bib22","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1002\/jps.21441","article-title":"Physicochemical characterization and stability of rifampicin liposome dry powder formulations for inhalation","volume":"98","author":"Changsan","year":"2009","journal-title":"J. Pharm. Sci."},{"issue":"1","key":"10.1016\/j.biomaterials.2019.119575_bib23","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/jps.21078","article-title":"Trileucine improves aerosol performance and stability of spray-dried powders for inhalation","volume":"97","author":"Lechuga-Ballesteros","year":"2008","journal-title":"J. Pharm. Sci."},{"issue":"1","key":"10.1016\/j.biomaterials.2019.119575_bib24","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.powtec.2007.03.046","article-title":"Amino acidmodified spray dried powders with enhanced aerosolisation properties for pulmonary drug delivery","volume":"178","author":"Seville","year":"2007","journal-title":"Powder Technol."},{"issue":"1\u20132","key":"10.1016\/j.biomaterials.2019.119575_bib25","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ijpharm.2008.03.024","article-title":"A comparative study of a range of polymeric microsphere as potential carriers for the inhalations of proteins","volume":"358","author":"Sivadas","year":"2008","journal-title":"Int. J. Pharm."},{"issue":"9","key":"10.1016\/j.biomaterials.2019.119575_bib26","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1007\/s11095-011-0443-4","article-title":"Insulin lung deposition and clearance following Technosphere\u00ae insulin inhalation powder administration","volume":"28","author":"Cassidy","year":"2011","journal-title":"Pharm. Res."},{"issue":"2","key":"10.1016\/j.biomaterials.2019.119575_bib27","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1021\/mp700096e","article-title":"A delineation of diketopiperazine self-assembly processes: understanding the molecular events involved in N\u03b5 -(Fumaroyl)diketopiperazine of L-Lys (FDKP) interactions","volume":"5","author":"Kaur","year":"2008","journal-title":"Mol. Pharm."},{"issue":"5","key":"10.1016\/j.biomaterials.2019.119575_bib28","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1177\/193229681000400515","article-title":"Pharmacokinetic characterization of the novel pulmonary delivery excipient fumaryl diketopiperazine","volume":"4","author":"Potocka","year":"2010","journal-title":"J. Diabetes Sci. Technol."},{"key":"10.1016\/j.biomaterials.2019.119575_bib29","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.biomaterials.2018.01.022","article-title":"Azithromycin-loaded respirable microparticles for targeted pulmonary delivery for the treatment of pneumonia","volume":"160","author":"Wang","year":"2018","journal-title":"Biomaterials"},{"issue":"6","key":"10.1016\/j.biomaterials.2019.119575_bib30","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1023\/A:1011936901638","article-title":"Mechanistic studies on effervescent-induced permeability enhancement","volume":"15","author":"Eichman","year":"1998","journal-title":"Pharm. Res."},{"issue":"3","key":"10.1016\/j.biomaterials.2019.119575_bib31","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.ejpb.2006.10.021","article-title":"Effervescent dry powder for respiratory drug delivery","volume":"65","author":"Ely","year":"2007","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"9","key":"10.1016\/j.biomaterials.2019.119575_bib32","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1080\/03639040802149079","article-title":"Formulation and in vivo evaluation of effervescent inhalable carrier particles for pulmonary delivery of nanoparticles","volume":"34","author":"Azarmi","year":"2008","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.biomaterials.2019.119575_bib33","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jcis.2014.12.092","article-title":"Inhalable nanostructured lipid particles of 9-bromo-noscapine, a tubulin-binding cytotoxic agent: in vitro and in vivo studies","volume":"445","author":"Jyoti","year":"2015","journal-title":"J. Colloid Interface Sci."},{"issue":"10","key":"10.1016\/j.biomaterials.2019.119575_bib34","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1016\/j.biomaterials.2008.12.044","article-title":"Development of highly porous large PLGA microparticles for pulmonary drug delivery","volume":"30","author":"Yang","year":"2009","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.biomaterials.2019.119575_bib35","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jconrel.2010.10.035","article-title":"Inhalable nanoparticles, a non-invasive approach to treat lung cancer in a mouse model","volume":"150","author":"Roa","year":"2011","journal-title":"J. Control. Release"},{"issue":"1\u20132","key":"10.1016\/j.biomaterials.2019.119575_bib36","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.ijpharm.2015.07.001","article-title":"Inhalable spray-dried formulation of D-LAK antimicrobial peptides targeting tuberculosis","volume":"491","author":"Kwok","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.biomaterials.2019.119575_bib37","series-title":"Standard Practice for Maintaining Constant Relative Humidity by Means of Aqueous Glycerin Solutions","author":"American Society for Testingand Materials","year":"2011"},{"issue":"2","key":"10.1016\/j.biomaterials.2019.119575_bib38","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.snb.2010.01.007","article-title":"Detection of low levels of Escherichia coli in fresh spinach by surface plasmon resonance spectroscopy with a TMB-based enzymatic signal enhancement method","volume":"145","author":"Linman","year":"2010","journal-title":"Sens. Actuators B Chem."},{"issue":"12","key":"10.1016\/j.biomaterials.2019.119575_bib39","doi-asserted-by":"crossref","first-page":"3332","DOI":"10.1039\/C8BM00628H","article-title":"Evaluation of absorbable hemostatic agents of polyelectrolyte complexes using carboxymethyl starch and chitosan oligosaccharide both in vitro and in vivo","volume":"6","author":"Chen","year":"2018","journal-title":"Biomaterials Science"},{"issue":"2","key":"10.1016\/j.biomaterials.2019.119575_bib40","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1084\/jem.20040731","article-title":"The scavenger receptor MARCO is required for lung defense against pneumococcal pneumonia and inhaled particles","volume":"200","author":"Arredouani","year":"2004","journal-title":"J. Exp. Med."},{"issue":"2","key":"10.1016\/j.biomaterials.2019.119575_bib41","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1093\/toxsci\/kfm050","article-title":"A murine scavenger receptor MARCO recognizes polystyrene nanoparticles","volume":"97","author":"Kanno","year":"2007","journal-title":"Toxicol. Sci."},{"issue":"4","key":"10.1016\/j.biomaterials.2019.119575_bib42","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1165\/rcmb.2006-0128OC","article-title":"The macrophage scavenger receptor SR-AI\/II and lung defense against pneumococci and particles","volume":"35","author":"Arredouani","year":"2006","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"9","key":"10.1016\/j.biomaterials.2019.119575_bib43","doi-asserted-by":"crossref","first-page":"6058","DOI":"10.4049\/jimmunol.175.9.6058","article-title":"MARCO is the major binding receptor for unopsonized particles and bacteria on human alveolar macrophages","volume":"175","author":"Arredouani","year":"2005","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.biomaterials.2019.119575_bib44","doi-asserted-by":"crossref","first-page":"5852","DOI":"10.3390\/ijms15045852","article-title":"Nanoparticle-mediated pulmonary drug delivery: a review","volume":"15","author":"Paranjpe","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biomaterials.2019.119575_bib45","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ejpb.2014.12.001","article-title":"Particle engineering to enhance or lessen particle uptake by alveolar macrophages and to influence the therapeutic outcome","volume":"89","author":"Patel","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.biomaterials.2019.119575_bib46","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.addr.2014.05.017","article-title":"Delivery strategies for sustained drug release in the lungs","volume":"75","author":"Pastoriza","year":"2014","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.biomaterials.2019.119575_bib47","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0927-7765(02)00042-5","article-title":"Phagocytic uptake of polystyrene microspheres by alveolar macrophages: effects of the size and surface properties of the microspheres","volume":"27","author":"Makino","year":"2003","journal-title":"Colloids Surfaces B Biointerfaces"},{"issue":"1","key":"10.1016\/j.biomaterials.2019.119575_bib48","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.colsurfb.2006.11.030","article-title":"Effects of lung surfactants on rifampicin release rate from monodisperse rifampicin-loaded PLGA microspheres","volume":"55","author":"Tomoda","year":"2007","journal-title":"Colloids Surfaces B Biointerfaces"},{"key":"10.1016\/j.biomaterials.2019.119575_bib49","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jconrel.2014.03.022","article-title":"Quantitative assessment of nanoparticle surface hydrophobicity and its influence on pulmonary biocompatibility","volume":"183","author":"Jones","year":"2014","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.biomaterials.2019.119575_bib50","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/s11095-008-9626-z","article-title":"Shape induced inhibition of phagocytosis of polymer particles","volume":"26","author":"Champion","year":"2019","journal-title":"Pharm. Res."},{"issue":"7","key":"10.1016\/j.biomaterials.2019.119575_bib51","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1002\/smll.200902074","article-title":"Shape-dependent cytotoxicity and proinflammatory response of poly(3,4-ethylenedioxythiophene) nanomaterials","volume":"6","author":"Oh","year":"2010","journal-title":"Small"},{"issue":"7","key":"10.1016\/j.biomaterials.2019.119575_bib52","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1039\/C8BM00282G","article-title":"Polymer-augmented liposomes enhancing antibiotic delivery against intracellular infections","volume":"6","author":"Su","year":"2018","journal-title":"Biomaterials Science"},{"issue":"8","key":"10.1016\/j.biomaterials.2019.119575_bib53","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1039\/C7BM00345E","article-title":"Surgical suture releasing macrophage-targeted drug-loaded nanoparticles for an enhanced anti-inflammatory effect","volume":"5","author":"Kim","year":"2017","journal-title":"Biomaterials Science"},{"issue":"7","key":"10.1016\/j.biomaterials.2019.119575_bib54","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1039\/C8BM00431E","article-title":"Understanding the effect of alkyl chains of gemini cations on the physicochemical and cellular properties of polyurethane micelles","volume":"6","author":"Pan","year":"2018","journal-title":"Biomaterials Science"},{"issue":"4","key":"10.1016\/j.biomaterials.2019.119575_bib55","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1039\/C8BM01545G","article-title":"Disparate effects of PEG or albumin based surface modification on the uptake of nano- and micro-particles","volume":"7","author":"Sharma","year":"2019","journal-title":"Biomaterials Science"},{"issue":"3","key":"10.1016\/j.biomaterials.2019.119575_bib56","doi-asserted-by":"crossref","first-page":"483","DOI":"10.2165\/00003495-199651030-00013","article-title":"Azilhromycin: a review of its pharmacological properties and use as 3-day therapy in respiratory tract infections","volume":"51","author":"Dunn","year":"1996","journal-title":"Drugs"}],"updated-by":[{"DOI":"10.1016\/j.biomaterials.2021.120679","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000}}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014296121930674X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014296121930674X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,11,6]],"date-time":"2019-11-06T19:58:38Z","timestamp":1573070318000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S014296121930674X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":56,"alternative-id":["S014296121930674X"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2019.119575","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.biomaterials.2021.120679","asserted-by":"object"}]},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fumaryl diketopiperazine based effervescent microparticles to escape macrophage phagocytosis for enhanced treatment of pneumonia via pulmonary delivery","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2019.119575","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"119575"}}